Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer.
Motobayashi H, Kitahata Y, Okada KI, Miyazawa M, Ueno M, Hayami S, Miyamoto A, Shimizu A, Sato M, Yoshimura T, Nakamura Y, Takemoto N, Nakai T, Hyo T, Matsumoto K, Yamaue H, Kawai M.
Motobayashi H, et al. Among authors: miyamoto a.
J Cancer Res Clin Oncol. 2024 Jan 26;150(2):35. doi: 10.1007/s00432-023-05594-1.
J Cancer Res Clin Oncol. 2024.
PMID: 38277079
Free PMC article.